1, 8-Naphthalimide based fluorescent sensors for enzymes

C Geraghty, C Wynne, RBP Elmes - Coordination Chemistry Reviews, 2021 - Elsevier
Fluorescent probes have long been valuable tools in the study of biological systems. With
the ever-expanding range of known enzymatic biomarkers for disease, it has never been …

[HTML][HTML] Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer

K Fujita, Y Kubota, H Ishida, Y Sasaki - World journal of …, 2015 - ncbi.nlm.nih.gov
Irinotecan hydrochloride is a camptothecin derivative that exerts antitumor activity against a
variety of tumors. SN-38 produced in the body by carboxylesterase is the active metabolite of …

4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer

N Nagy, HF Kuipers, AR Frymoyer, HD Ishak… - Frontiers in …, 2015 - frontiersin.org
Hyaluronan (HA) is a prominent component of the extracellular matrix at many sites of
chronic inflammation, including type 1 diabetes (T1D), multiple sclerosis, and numerous …

Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression

EP Allain, M Rouleau, E Lévesque… - British journal of …, 2020 - nature.com
The best-known role of UDP-glucuronosyltransferase enzymes (UGTs) in cancer is the
metabolic inactivation of drug therapies. By conjugating glucuronic acid to lipophilic drugs …

The role of uptake and efflux transporters in the disposition of glucuronide and sulfate conjugates

E Järvinen, F Deng, W Kiander, A Sinokki… - Frontiers in …, 2022 - frontiersin.org
Glucuronidation and sulfation are the most typical phase II metabolic reactions of drugs. The
resulting glucuronide and sulfate conjugates are generally considered inactive and safe …

Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and …

JO Miners, TM Polasek, JA Hulin, A Rowland… - Pharmacology & …, 2023 - Elsevier
Drug-drug interactions (DDIs) arising from the perturbation of drug metabolising enzyme
activities represent both a clinical problem and a potential economic loss for the …

[HTML][HTML] Drug metabolizing enzymes and their inhibitors' role in cancer resistance

S Pathania, R Bhatia, A Baldi, R Singh… - Biomedicine & …, 2018 - Elsevier
Despite continuous research on chemotherapeutic agents, different mechanisms of
resistance have become a major pitfall in cancer chemotherapy. Although, exhaustive efforts …

Age‐and genotype‐dependent variability in the protein abundance and activity of six major uridine diphosphate‐glucuronosyltransferases in human liver

DK Bhatt, A Mehrotra, A Gaedigk… - Clinical …, 2019 - Wiley Online Library
The ontogeny of hepatic uridine diphosphate‐glucuronosyltransferases (UGTs) was
investigated by determining their protein abundance in human liver microsomes isolated …

SNPs in 3′ UTR miRNA target sequences associated with individual drug susceptibility

E Rykova, N Ershov, I Damarov… - International Journal of …, 2022 - mdpi.com
The complementary interaction of microRNAs (miRNAs) with their binding sites in the 3′
untranslated regions (3′ UTRs) of target gene mRNAs represses translation, playing a …

[HTML][HTML] Reciprocal interplays between MicroRNAs and pluripotency transcription factors in dictating stemness features in human cancers

R Vishnubalaji, H Shaath, M Al-Alwan… - Seminars in Cancer …, 2022 - Elsevier
The interplay between microRNAs (miRNAs) and pluripotency transcription factors (TFs)
orchestrates the acquisition of cancer stem cell (CSC) features during the course of …